Two drug combinations of zidovudine, didanosine, and recombinant interferon-alpha inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro.
D016049:Didanosine / Q000008:administration & dosage; D004357:Drug Synergism; D015658:HIV Infections / Q000188:drug therapy / Q000628:therapy; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D007370:Interferon Type I / Q000008:administration & dosage; D011994:Recombinant Proteins; D014779:Virus Replication / Q000187:drug effects; D015215:Zidovudine / Q000008:administration & dosage
D007370:Interferon Type I; D011994:Recombinant Proteins; D015215:Zidovudine; D016049:Didanosine